Airmid’s team comprises senior executives, clinicians, and researchers with broad expertise in all aspects of drug discovery, pharmaceutical manufacturing, development and commercialization, finance, and business development. Members include internationally recognized authorities on design and execution of preclinical and clinical studies, peptide and small molecule therapeutics, ion channels and cellular immunity, medicinal and synthetic chemistry, and in vivo and in vitro pharmacology.